Back to Research News Research News and Information

2275 Swallow Hill Road - Building 2500 - Pittsburgh, PA 15220
(412) 429-0673 Fax: (412) 279-1367

Press Release


Pittsburgh, PA - January 23, 1997 - Biocontrol Technology, Inc. (NASDAQ:BICO) announced today that an in-home study of the Diasensor 1000TM noninvasive glucose sensor will begin February 3, 1997 as the various issues concerning the study protocol have been addressed with the Food and Drug Administration (FDA).

Although there can be no guarantees, the Company anticipates that the study will take approximately 120 days to complete. Once the study is completed, the Company will resubmit its 510(k) application with the new data to the FDA for approval to market the Diasensor 1000 in the United States.

The Company also stated that further details of the study will remain confidential at this time.

Without the need to finger prick as current monitors require, the Diasensor 1000 measures blood glucose levels using near infrared technology.

Biocontrol Technology, Inc. has its corporate offices in Pittsburgh, PA and is involved in the development and manufacture of biomedical devices and environmental products.


  Back to Research News Return to the Top of This Page

Last Updated: Thursday February 27, 2014 19:28:21
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.